Login / Signup

Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes.

Piyush K JainJustin H LoSantosh R RananawareMarco DowningApekshya PandaMichelle TaiSrivatsan RaghavanSangeeta N BhatiaSangeeta N Bhatia
Published in: Nanoscale (2019)
There is a critical need for the development of safe and efficient delivery technologies for CRISPR/Cas9 to advance translation of genome editing to the clinic. Non-viral methods that are simple, efficient, and completely based on biologically-derived materials could offer such potential. Here we report a simple and modular tandem peptide-based nanocomplex system with cell-targeting capacity that efficiently combines guide RNA (sgRNA) with Cas9 protein, and facilitates internalization of sgRNA/Cas9 ribonucleoprotein complexes to yield robust genome editing across multiple cell lines.
Keyphrases
  • genome editing
  • crispr cas
  • sars cov
  • single cell
  • primary care
  • cancer therapy
  • cell therapy
  • protein protein
  • stem cells
  • amino acid
  • drug delivery
  • dna methylation
  • small molecule
  • binding protein